Reduction of paraquat and related bipyridylium compounds to free radical metabolites by rat hepatocytes.
The toxicity of paraquat is due to the oxygen-derived radicals formed by the reaction of oxygen with bipyridylium radical cations. Although paraquat is known to cause lung toxicity, the related bipyridylium compounds such as diquat and morfamquat do not affect the lung as seriously, but rather cause liver toxicity. Paraquat, diquat, morfamquat, and benzyl viologen are reduced by rat hepatocytes to their respective radical cations. An intracellular component of the signal was detected from diquat and benzyl viologen radical cations. These radical cations generated inside the cell can cross the plasma membrane. Generation of the diquat radical cation by hepatocytes is not affected by the inhibition of cytochrome P-450 by carbon monoxide or metyrapone, suggesting that this enzyme is probably not involved in the reduction of diquat as had been proposed previously. The reduction of paraquat is generally attributed to NADPH-cytochrome P-450 reductase, and presumably diquat is also reduced by this flavoprotein. Some transition metal chelates such as ferric diethylenetriaminepentaacetic acid delay the detection of the diquat radical cation. This may be due to the reduction of the ferric chelate by the diquat radical cation resulting in the formation of the ferrous chelate and the parent bipyridylium dication. When all the ferric chelate has been reduced to the ferrous chelate, then the bipyridylium radical can be detected. Alternatively, if the ferric chelate enters the cell, it can compete with the parent bipyridylium dication for the reductase, which would also lead to delayed detection.
DeGray
J A
JA
Laboratory of Molecular Biophysics, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709.
Rao
D N
DN
Mason
R P
RP
D000818:Animals; D001594:Benzyl Viologen / Q000378:metabolism; D002412:Cations; D056486:Chemical and Drug Induced Liver Injury; D003035:Cobalt / Q000494:pharmacology; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D004178:Diquat / Q000378:metabolism; D004578:Electron Spin Resonance Spectroscopy; D005609:Free Radicals; D008099:Liver / Q000378:metabolism*; D008297:Male; D008797:Metyrapone / Q000494:pharmacology; D009249:NADP / Q000494:pharmacology; D009251:NADPH-Ferrihemoprotein Reductase / Q000378:metabolism; D010084:Oxidation-Reduction; D010269:Paraquat / Q000378:metabolism* / Q000633:toxicity; D004369:Pentetic Acid / Q000494:pharmacology; D011726:Pyridinium Compounds / Q000378:metabolism; D051381:Rats
D002412:Cations; D005609:Free Radicals; D011726:Pyridinium Compounds; D001594:Benzyl Viologen; C008547:morfamquat; D003035:Cobalt; D009249:NADP; D004369:Pentetic Acid; D003577:Cytochrome P-450 Enzyme System; D004178:Diquat; D009251:NADPH-Ferrihemoprotein Reductase; D010269:Paraquat; D008797:Metyrapone